Published in Neurol Sci on September 01, 2002
Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel) (2013) 1.16
Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol (2012) 0.97
Drooling in Parkinson's disease: a review. Parkinsonism Relat Disord (2014) 0.91
A pilot study of respiration and swallowing integration in Parkinson's disease: "on" and "off" levodopa. Dysphagia (2007) 0.88
Management of drooling in disabled patients with scopolamine patches. Br J Clin Pharmacol (2010) 0.87
Self-reported dysphagia and its correlates within a prevalent population of people with Parkinson's disease. Dysphagia (2011) 0.87
A therapeutic maneuver for oropharyngeal dysphagia in patients with Parkinson's disease. Clinics (Sao Paulo) (2008) 0.83
Tongue force and tongue motility are differently affected by unilateral vs bilateral nigrostriatal dopamine depletion in rats. Behav Brain Res (2012) 0.82
Early identification and treatment of communication and swallowing deficits in Parkinson disease. Semin Speech Lang (2013) 0.81
Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson's disease. Dysphagia (2009) 0.81
A systematic review of self-reported swallowing assessments in progressive neurological disorders. Dysphagia (2014) 0.79
Wet voice as a sign of penetration/aspiration in Parkinson's disease: does testing material matter? Dysphagia (2014) 0.75
Multimodal Swallowing Evaluation with High-Resolution Manometry Reveals Subtle Swallowing Changes in Early and Mid-Stage Parkinson Disease. J Parkinsons Dis (2016) 0.75
Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease? PLoS One (2016) 0.75
An unusual complication of Botox treatment for sialorrhoea. Int J Surg Case Rep (2014) 0.75
Assessment of Oropharyngeal Dysphagia in Patients With Parkinson Disease: Use of Ultrasonography. Ann Rehabil Med (2016) 0.75
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2002) 2.72
Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia (2007) 2.52
Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care (2001) 2.45
Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ (1997) 2.33
Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology (2001) 2.24
Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia (2002) 2.23
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology (2004) 2.04
Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology (2010) 2.03
Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry (2007) 2.03
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (2001) 2.00
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol (2011) 1.93
Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol (2000) 1.88
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology (2010) 1.85
Paraplegia following coeliac plexus block. Pain (1993) 1.85
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology (2009) 1.78
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". Neurology (2001) 1.76
Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. AJNR Am J Neuroradiol (2001) 1.75
The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology (2006) 1.72
Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol (1994) 1.72
Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia (1996) 1.70
Epidemiology: bridges over (and across) roaring levels. J Epidemiol Community Health (1998) 1.69
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64
A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients. J Neurol Neurosurg Psychiatry (2009) 1.64
Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology (2008) 1.63
Poverty, health services, and health status in rural America. Milbank Q (1988) 1.61
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain (2003) 1.60
Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue. AJNR Am J Neuroradiol (2011) 1.58
Denaturing gradient gel electrophoresis analysis of the 16S rRNA gene V1 region to monitor dynamic changes in the bacterial population during fermentation of Italian sausages. Appl Environ Microbiol (2001) 1.57
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease. J Neurol Neurosurg Psychiatry (1989) 1.54
Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol (1999) 1.54
Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int J Food Microbiol (2001) 1.52
Screening and prevention of diabetic blindness. Acta Ophthalmol Scand (2000) 1.51
Ethics of ignorance: lessons from the epidemiological assessment of the bovine spongioform encephalopathy ("mad cow disease") epidemic. Perspect Biol Med (1998) 1.51
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain (2007) 1.48
Success and failure at inpatient heroin detoxification. Br J Addict (1989) 1.48
Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol (1998) 1.44
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44
Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg Psychiatry (2000) 1.43
IFCN standards for digital recording of clinical EEG. International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol (1998) 1.43
Abnormal cervical cord function contributes to fatigue in multiple sclerosis. Mult Scler (2012) 1.42
The "mirror-neuron system" in MS: A 3 tesla fMRI study. Neurology (2007) 1.42
Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol (1999) 1.42
Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage (2002) 1.41
Towards a european network for multiple sclerosis trials (ENMST). Mult Scler (2003) 1.40
Neurodegeneration in the course of Langerhans cell histiocytosis. Neurol Sci (2011) 1.40
Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group. Neurology (2000) 1.39
Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment. Ital J Neurol Sci (1996) 1.39
Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care (2001) 1.38
A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology (1995) 1.38
Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet (1982) 1.35
Effects of seasons on magnetic resonance imaging--measured disease activity in patients with multiple sclerosis. Ann Neurol (2001) 1.35
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol (2001) 1.29
Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol (1999) 1.28
Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain (1996) 1.27
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol (1999) 1.27
Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology (2010) 1.27
Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract (2006) 1.26
Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer (1994) 1.25
Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology (2004) 1.22
The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology (2010) 1.22
Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler (2007) 1.21
A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology (2011) 1.20
Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology (2001) 1.20
Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. Brain (1995) 1.20
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther (2008) 1.18
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care (1997) 1.17
In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain (2001) 1.17
Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol (2008) 1.16
Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol (2001) 1.16
A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care (2000) 1.15
Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology (1998) 1.15
A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol (2000) 1.14
Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler (2009) 1.13
Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol (1992) 1.13
Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci (1994) 1.12
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study. Neurol Sci (2011) 1.11
Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology (2001) 1.11
Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol (1997) 1.10
White matter damage in frontotemporal lobar degeneration spectrum. Cereb Cortex (2011) 1.10
Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis. Neurology (2004) 1.09
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. Ann Neurol (2009) 1.09
Altered functional and structural connectivities in patients with MS: a 3-T study. Neurology (2007) 1.09
Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy (VATET) in patients with myasthenia gravis. Int Surg (1996) 1.09
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. Brain (2001) 1.08
Bone metabolism in type 2 diabetes mellitus. Acta Diabetol (1999) 1.08
A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology (2000) 1.08